![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Publication history |
Reprints |
Permissions |
Cite this article as |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
REVIEW
Minerva Chirurgica 2017 December;72(6):520-9
DOI: 10.23736/S0026-4733.17.07437-5
Copyright © 2017 EDIZIONI MINERVA MEDICA
language: English
Colitis-associated colorectal cancer in patients with inflammatory bowel disease
Se-Jin BAEK, Seon-Hahn KIM ✉
Department of Surgery, Korea University College of Medicine, Seoul, South Korea
Colitis-associated colorectal cancer (CACRC) is a major concern in patients with long-standing inflammatory bowel disease (IBD). CACRC can develop under the influence of several risk factors including longer duration and disease extent and shows clinical and molecular features different from those of sporadic CRC. Several academic societies have recommended surveillance guidelines for CACRC that develops in IBD patients. Patients are stratified according to risk for CRC and differentiated by surveillance colonoscopy and management. In the current article, we review CACRC in IBD patients generally and introduce future directions.
KEY WORDS: Inflammatory bowel diseases - Colitis, ulcerative - Crohn disease - Colorectal neoplasms - Colonoscopy